(Q33584015)

28 July 2017

title

Acquired hepatocerebral degeneration: clinical characteristics and MRI findings (English)

1 reference

magnetic resonance imaging

28 July 2017

main subject

0 references

author name string

R Fernández-Rodriguez

1

1 reference

28 July 2017

A Contreras

2

1 reference

28 July 2017

J G De Villoria

3

1 reference

28 July 2017

F Grandas

4

1 reference

28 July 2017

publication date

1 December 2010

1 reference

European Journal of Neurology

28 July 2017

published in

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

12

1 reference

28 July 2017

page(s)

1463-1470

1 reference

Chronic acquired hepatocerebral degeneration: case reports and new insights.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Portosystemic myelopathy: spastic paraparesis after portosystemic shunting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Acquired hepatocerebral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Whole blood manganese correlates with high signal intensities on T1-weighted MRI in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

The natural history of neurological manganism over 18 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Progression after chronic manganese exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

A Parkinsonian syndrome in methcathinone users and the role of manganese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Clinical significance of extrapyramidal signs in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Manganese elevations in blood of children with congenital portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Development of chronic hepatocerebral degeneration eight years after a distal splenorenal (Warren) shunt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Orofacial dyskinesias in a patient with primary biliary cirrhosis: a clinicopathological case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Distribution of cerebral lesions in acquired hepatocerebral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Hypermanganesemia in patients receiving total parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Long-term outcome of brain manganese deposition in patients on home parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Treatment of chronic hepatic encephalopathy with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Cerebral magnetic resonance imaging in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Hepatic cirrhosis: magnetisation transfer contrast in the globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

MRI findings associated with acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Acquired (non-Wilsonian) hepatocerebral degeneration: complex management decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Acquired hepatocerebral degeneration: full recovery after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Reversal of parkinsonism following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

Cognitive functioning in chronic acquired hepatocerebral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03076.X

10.1111/J.1468-1331.2010.03076.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference